Mafenide is a sulfonamide antibiotic indicated for the prevention and treatment of wound infections in patients with severe burns. By inhibiting bacterial dihydropteroate synthase, the medication interferes… Read more
Mafenide is a sulfonamide antibiotic indicated for the prevention and treatment of wound infections in patients with severe burns. By inhibiting bacterial dihydropteroate synthase, the medication interferes with the folate synthesis essential for bacterial growth. To support pharmaceutical analysis, this category provides high-quality reference standards for Mafenide and its related compounds. Laboratories utilize these materials for impurity profiling, method validation, and rigorous quality control testing. The selection includes the active pharmaceutical ingredient, its hydrochloride salt form, and specific process-related impurities such as 4-formylbenzenesulfonamide and m-toluenesulfonyl chloride. Access to these characterized standards allows for the precise identification and quantification of impurities in drug substances and finished products, ensuring compliance with pharmacopeial standards and safety requirements during the manufacturing and development of topical antibacterial formulations.